ANALYSIS OF FACTORS AFFECTING THE COMPLIANCE WITH MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA
- Authors: Malkhasyan V.A.1, Rasner P.I.1, Gevorkyan A.R.2, Semenyakin I.V.3, Tedeev A.V.1, Pushkar D.Y.1
-
Affiliations:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Outpatient Clinic № 195, MHD
- S.I. Spasokukotsky CCH, MHD
- Issue: No 2 (2017)
- Pages: 36-41
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/322117
- DOI: https://doi.org/10.18565/urol.2017.2.36-41
- ID: 322117
Cite item
Open Access
Access granted
Abstract
Aim To investigate factors affecting the compliance of patients with the combination therapy for benign prostatic hyperplasia. Materials and methods Four hundred BPH outpatients treated with combination therapy were surveyed. Results The absolute majority of patients (76.16%) expected a quick positive result. 10.47% viewed their disease as too advanced, did not believe in the effectiveness of medical therapy and believed the surgery to be the only treatment option. 24.42% of patients changed the medication dosage on their own, and 11% were ready to discontinue the treatment without consulting their doctors. 76.16% of patients considered the recommended treatment to be effective, 77.33% fully trusted the doctor. In the opinion of 8.7% of patients, the doctor did not sufficiently inform them about the prescribed drug. 22.67% of patients had doubts about a physician’s competence, and 5.23% believed the doctor complicated their medical treatment and changed prescriptions too often. Conclusions The patients had a high level of trust in doctors and showed psychological adherence to therapy. However, about a quarter of patients changed the treatment regimen on their own. Many patients had exaggerated expectations of the treatment. 8% of patients reported insufficient awareness regarding the nature and appropriateness of drug therapy, and one in five patients had difficulties in perceiving, remembering and following the treatment regimen. Conclusion: streamlining therapeutic regimens, prescribing non-titratable or combined drugs will help improve patients’ therapy compliance.
Full Text
About the authors
V. A. Malkhasyan
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: vigenmalkhasyan@gmail.com
PhD, Teaching Assistant at the Department of Urology Moscow, Russia
P. I. Rasner
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: dr.rasner@gmail.com
Dr.Med.Sci., Prof. at the Department of Urology Moscow, Russia
A. R. Gevorkyan
Outpatient Clinic № 195, MHD
Email: Ashot_Gevorkyan@mail.ru
PhD,Head of the Department of Urology Moscow, Russia
I. V. Semenyakin
S.I. Spasokukotsky CCH, MHD
Email: iceig@mail.ru
Dr.Med.Sci., Deputy Chief Physician for Surgery Moscow, Russia
A. V. Tedeev
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: dr_tedeev@mail.ru
PhD Student at the Department of Urology Moscow, Russia
D. Yu. Pushkar
A.I. Evdokimov Moscow State University of Medicine and Dentistry
Email: dmitry.pushkar@mail.com
Corr.-Member of the RAS, Dr.Med.Sci., Prof., Head of the Department of Urology; Chief Urologist of Minzdrav of Russia Moscow, Russia
References
- Park H., Won J., Sorsaburu S., Rivera P., Lee S. Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalaffl. World J Mens Health. 2013;31(3):193-207.
- Garraway W.M., Collins G.N., Lee R.J. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;(338):469-471.
- Kornev I.A., Alekseeva T.A., Kogan M.I., Pushkar’ D.Y. Epidemiology of lower urinary tract symptoms in Russia. Urologiia 2016;2(2):1-9.
- Kupelian V., Wei J.T., O’Leary M.P. et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston area community health (BACH) survey. Arch intern med 2006;166:2381-2387.
- Black L., Naslund M.J., Gilbert E.A. Davis D.A. An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia. The American journal of managed care. 2006;12(4):99-110.
- Holtgrewe, H.L. Economic issues and the management of benign prostatic hyperplasia. Urology. 1995;46(3):23-25.
- Lames F. S., Sandra S.M. Alexander A. Cost Density Analysis of Benign Prostatic Hyperplasia. Clinical Therapeutics. 1996;18(5):993-1004.
- Apolikhin O.I., Sivkov O.I., Shishkin S.V., Sheyman I.M., Son I.M., Katibov M.I., Zolotukhin O.V., Shaderkin I.A., Prosyannikov M.Y. Socio-economic aspects of complex BPH diagnostic programe. Klinicheskaya i experimentalnaya urologiia. 2014;3.
- Gorilovskiy L.M., Lazebnik L.B., Sboyeva S. G., Kaysarov D.E. Socio-economic issues of BPH treatment in Moscow. Problemi standartizacii v zdravookhranenii. 2000;4:24-31
- Polyakov V.V. Comparative estimation of efficiency of α-blockers in BPH treatment. Vesti novikh medtekhnologiy. 2007;14(3):74-75
- Roehrborn C., Nickel J., Andriole G., Gagnier R., Black L., Wilson T., Rittmaster R. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the reduction by dutasteride of prostate Cancer Events (REDUCE) trial. Urology. 2011;78(3):641-646. doi: 10.1016/j.urology.2011.03.063.
- Claus G. R., Paul S., Jack B., Ronaldo D., Kim M.-W., Indrani N.Y., Betsy B.M., R. Paul G., Francesco M. on behalf of the CombAT Study Group Eur Urol. 2010;58(5):801.
- Pushkar’ D.Yu., Malkhasyan V.A., Khodyreva L.A., Rasner P.I., Kupriyanov Yu.A., Dudareva A.A. Analysis of medical care and optimazation for patients with acute urinary retention admitted to hospital in Moscow. Eksperimental’naya i klinicheskaya urologiya 2016;2.
- Hutchison A. The Efficacy of Drugs for the Treatment of LUTS/ BPH. A Study in 6 European Countries / A. Hutchison, R. Farmer, K. Verhamme, R. Berges, R. Navarrete. Eur. Urol. 2007;51(1): 207-216.
- Luca C., Luisella P., Caterina F., Marilena R., Andrea T., Riccardo A., Cosimo De N., Luigi S. Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study European urology 68. 2015:418-425.
- Atreja A., Bellam N., Levy S.R. Strategies to Enhance Patient Adherence: Making it Simple. Medscape General Medicine. 2005;7(1):4.
- Jackevicius C.A., Li P., Tu J.V. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117:1028-1036.
- World Health Organization. Secondary prevention of noncommunicable disease in low and middle-income countries through community-based and health service interventions. Wellcome Trust meeting report. 1-3 Aug 2001. WHO, 2002.
- Shal’nova S.A., Deev A.D., Karpov Yu.A. Arterial hypertension in cardiologist practice. Kardiovaskulyarnaya terapiya i profilaktika. 2006;5(2):73-80.
- Briesacher B.A., Andrade S.E., Fouayzi H. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;8(4):437-443.
- Stewart K., George J., Mc Namara K.P. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial). J Clin Pharm Ther. 2014;39(5):527-534.
- Simpson S., Eurich D., Majumdar S. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15-20.
- Barreto M., Cremonese I., Janeiro V. Prevalence of non-adherence to antihypertensive pharmacotherapy and associated factors. Rev Bras Enferm. 2015;68(1):60-67.
- Conn V., Hafdahl A., Cooper P. Interventions to Improve Medication Adherence Among Older Adults: Meta-Analysis of Adherence Outcomes Among Randomized Controlled Trials. Gerontologist. 2009;49(4):447-462.
- Lowes R. Healthcare Reform Sets Stage for Better Medication Adherence. The New England Journal of Medicine. 2010;7.
- Al Hewiti A. Adherence to Long-Term Therapies and Beliefs about Medications. International Journal of Family Medicine. 2014: 479596. doi: 10.1155/2014/479596.
- Braddock C.H., Fihn S., Levinson W. How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting. J Gen Intern Med. 1997;12:339-345.
- Ley P. Memory for medical information. Br J Soc Clin Psychol. 1979;18:245-266.
- Ley P. Patients’ understanding and recall in clinical communication failure. In: Pendleton D, Hasler J, editors. Doctor-patient communication. London: Academic Press, Inc. 1983:89-107.
- Britten N., Stevenson F., Barry C. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ. 2000;320: 484-488.
Supplementary files
